This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
pot-stocks: Archive
Epidolex Progresses: Will the Marijuana Drug Market Boom?
by Indrajit Bandyopadhyay
Cannabis (or marijuana) based medical products have the potential to become the next booming industry.
GWPHPositive Net Change ZYNEPositive Net Change CGCNegative Net Change ACBNegative Net Change TLRYPositive Net Change CRONNegative Net Change
marijuana medical pharmaceuticals pot-stocks
Cannabis Industry to Scale New Highs Amid Legalization Woes
by Nilanjan Gupta
Legalization will likely drive commercial distribution of cannabis and boost growth of companies operating in this space.
GWPHPositive Net Change SMGNegative Net Change IIPRNegative Net Change ACBNegative Net Change CGCNegative Net Change CRONNegative Net Change
agriculture marijuana medical pot-stocks
Scotts Miracle-Gro (SMG) Stock Up 16% in 3 Months: Here's Why
by Zacks Equity Research
Better-than-expected Q3 results, upbeat view as well as bright prospects in the Hawthorne unit are driving Scotts Miracle-Gro's (SMG) shares.
KGCPositive Net Change AGIPositive Net Change ARNCPositive Net Change SMGNegative Net Change
agriculture basic-materials pot-stocks
Will Opioid Litigation Take its Toll on Pharma Companies?
by Indrajit Bandyopadhyay
Thousands of pending opioid-abuse lawsuits against several pharma companies come into limelight after the Oklahoma ruling against J&J. Let's see what's in store for these companies.
JNJNegative Net Change AGNPositive Net Change ENDPPositive Net Change TEVAPositive Net Change MNKPositive Net Change
biotechs marijuana medical pharmaceuticals pot-stocks
Why Scotts Miracle-Gro is Worth Adding to Your Portfolio Now
by Zacks Equity Research
Strong Q3 results, upward estimate revision and upbeat outlook makes Scotts Miracle-Gro (SMG) an appropriate investment option at the moment.
AGIPositive Net Change KGCPositive Net Change ARNCPositive Net Change SMGNegative Net Change
agriculture basic-materials pot-stocks
Scotts Miracle-Gro (SMG) Tops Q3 Earnings & Sales Estimates
by Zacks Equity Research
The Sunlight Supply acquisition drives Scotts Miracle-Gro's (SMG) Hawthorne segment in Q3.
KGCPositive Net Change ARNCPositive Net Change SMGNegative Net Change SSRMNegative Net Change
agriculture basic-materials earnings marijuana pot-stocks
Scotts Miracle-Gro Hits 52-Week High: What's Driving it?
by Zacks Equity Research
Upbeat outlook for fiscal 2019 is driving Scotts Miracle-Gro's (SMG) shares.
FSIPositive Net Change FSUGYNegative Net Change BHPNegative Net Change SMGNegative Net Change
basic-materials cannabis marijuana pot-stocks
5 Pot Stock Earnings Charts
by Tracey Ryniec
It's an emerging industry, but are companies actually beating on earnings?
IIPRNegative Net Change ACBNegative Net Change TLRYPositive Net Change CRONNegative Net Change CGCNegative Net Change
earnings pot-stocks
4 Marijuana Stocks to Watch in 2019
by Tirthankar Chakraborty
According to Arcview Market Research and BDS Analytics, global consumer marijuana outlays are estimated to climb 38% to $16.9 billion this year, up from a projected $12.2 billion last year, $9.5 billion in 2017, and $6.9 billion in 2016.
STZNegative Net Change GWPHPositive Net Change IIPRNegative Net Change KSHBNo Net Change CGCNegative Net Change
marijuana marijuana-stocks pot-stocks
Pot Stocks: Who Has the Best Earnings Chart?
by Tracey Ryniec
Pot stocks are entering the investing mainstream but do they have what it takes to compete against mature industries?
IIPRNegative Net Change TLRYPositive Net Change CGCNegative Net Change CRONNegative Net Change ACBNegative Net Change
earnings pot-stocks
Pot Stocks in 2019: A Year of Transition
by Tracey Ryniec
In 2018, investors pinned their pot stock hopes on Canadian legalization but in 2019 the game has changed. Who will emerge as the winners?
STZNegative Net Change GWPHPositive Net Change MOPositive Net Change TLRYPositive Net Change ACBNegative Net Change
cannabis pot-stocks